Holen Sie sich die Stockscreener-App
8.93
0.11%
0.010
Handel nachbörslich:
9.12
0.19
+2.13%
Schlusskurs vom Vortag:
$8.92
Offen:
$9.01
24-Stunden-Volumen:
1.63M
Relative Volume:
1.38
Marktkapitalisierung:
$501.29M
Einnahmen:
$27.46M
Nettoeinkommen (Verlust:
$-46.05M
KGV:
-6.9225
EPS:
-1.29
Netto-Cashflow:
$-33.83M
1W Leistung:
-3.98%
1M Leistung:
-20.62%
6M Leistung:
+20.84%
1J Leistung:
+24.20%
1-Tages-Spanne:
$8.645
$9.08
1-Wochen-Bereich:
$8.645
$9.39
52-Wochen-Spanne:
$6.19
$13.16
Zevra Therapeutics Inc Stock (ZVRA) Company Profile
Firmenname
Zevra Therapeutics Inc
Sektor
Branche
Telefon
(321) 939-3416
Adresse
1180 CELEBRATION BOULEVARD, SUITE 103, CELEBRATION
Vergleichen Sie ZVRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZVRA
Zevra Therapeutics Inc
|
8.93 | 510.83M | 27.46M | -46.05M | -33.83M | -1.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Zevra Therapeutics Inc Stock (ZVRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-08 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2024-10-07 | Eingeleitet | Guggenheim | Buy |
| 2024-09-24 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-09-24 | Bestätigt | Maxim Group | Buy |
| 2024-04-02 | Bestätigt | Maxim Group | Buy |
| 2024-03-12 | Eingeleitet | William Blair | Outperform |
| 2023-03-17 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Zevra Therapeutics Inc Aktie (ZVRA) Neueste Nachrichten
Fund Flows: What is Zevra Therapeutics Inc.’s market positionProfit Target & Fast Momentum Stock Entry Tips - khodrobank.com
How does Zevra Therapeutics Inc. compare to its peersJuly 2025 Opening Moves & Community Verified Trade Alerts - khodrobank.com
What recovery options are there for Zevra Therapeutics Inc.2025 Historical Comparison & Precise Swing Trade Entry Alerts - Newser
Volume spikes in Zevra Therapeutics Inc. stock – what they mean2025 Market Sentiment & Weekly Stock Breakout Alerts - Newser
Quantitative breakdown of Zevra Therapeutics Inc. recent moveJuly 2025 Breakouts & AI Optimized Trade Strategies - Newser
Does Zevra Therapeutics Inc. meet Warren Buffett’s criteria2025 Market Overview & Weekly Chart Analysis and Trade Guides - khodrobank.com
Predicting Zevra Therapeutics Inc. trend using moving averages2025 Growth vs Value & AI Enhanced Trading Signals - Newser
Zevra Therapeutics Inc. stock chart pattern explained2025 Retail Activity & Verified Entry Point Signals - Newser
Using Python tools to backtest Zevra Therapeutics Inc. strategiesJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - Newser
What makes Zevra Therapeutics Inc. stock price move sharplyJuly 2025 Technicals & Verified Swing Trading Watchlists - Newser
How to manage a losing position in Zevra Therapeutics Inc.2025 Winners & Losers & Fast Exit and Entry Strategy Plans - Newser
Can Zevra Therapeutics Inc. recover in the next quarterChart Signals & Community Trade Idea Sharing Platform - Newser
Relative strength of Zevra Therapeutics Inc. in sector analysisTrade Risk Summary & Comprehensive Market Scan Insights - Newser
Measuring Zevra Therapeutics Inc.’s beta against major indices2025 Price Momentum & Target Return Focused Stock Picks - Newser
Is Zevra Therapeutics Inc. still worth holding after the dipJuly 2025 Decliners & Smart Investment Allocation Insights - Newser
Full technical analysis of Zevra Therapeutics Inc. stock2025 Key Highlights & Reliable Price Breakout Signals - Newser
Advanced analytics toolkit walkthrough for Zevra Therapeutics Inc.Jobs Report & Growth Oriented Trading Recommendations - Newser
How to build a dashboard for Zevra Therapeutics Inc. stockWeekly Stock Report & Short-Term High Return Ideas - Newser
Zevra Therapeutics gains amid takeover speculation - MSN
Is now a turning point for Zevra Therapeutics Inc.Market Risk Summary & Free Low Drawdown Momentum Trade Ideas - Newser
Is Zevra Therapeutics Inc. stock overhyped or has real potentialMarket Activity Summary & Real-Time Stock Price Movement Reports - Newser
Custom strategy builders for tracking Zevra Therapeutics Inc.2025 Buyback Activity & Fast Gain Stock Trading Tips - Newser
Is Zevra Therapeutics Inc. stock bottoming outJuly 2025 Decliners & AI Optimized Trading Strategy Guides - Newser
Real time scanner hits for Zevra Therapeutics Inc. explainedQuarterly Growth Report & Capital Efficient Trade Techniques - Newser
Analyzing drawdowns of Zevra Therapeutics Inc. with statistical toolsWeekly Trade Review & AI Driven Price Predictions - Newser
Is Zevra Therapeutics Inc. stock showing strong momentumEarnings Growth Summary & Growth Focused Stock Pick Reports - خودرو بانک
Favourable Signals For Zevra Therapeutics: Numerous Insiders Acquired Stock - Yahoo Finance
Aug Update: What are Zevra Therapeutics Inc.’s earnings expectationsTrade Performance Summary & Long-Term Safe Investment Plans - khodrobank.com
Zevra Therapeutics Inc. stock retracement – recovery analysisVolume Spike & Real-Time Price Movement Reports - Newser
Does Zevra Therapeutics Inc. qualify in momentum factor screening2025 Bull vs Bear & Growth Focused Entry Point Reports - Newser
Risk adjusted return profile for Zevra Therapeutics Inc. analyzedWeekly Investment Recap & Weekly Return Optimization Plans - Newser
Is It Too Early to Call Recovery in Zevra Therapeutics Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Zevra Therapeutics Faces $58.7 Million Impairment Charge, Raising Concerns Over Financial Stability - MSN
Tools to monitor Zevra Therapeutics Inc. recovery probabilityPortfolio Gains Summary & Advanced Technical Analysis Signals - Newser
Finanzdaten der Zevra Therapeutics Inc-Aktie (ZVRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Zevra Therapeutics Inc-Aktie (ZVRA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Thompson Rahsaan | Chief Legal & Compliance |
Jun 26 '25 |
Sale |
9.21 |
24,000 |
221,004 |
42,666 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):